The antimicrobial action of different components present in essential oils including carvacrol, 24 cinnamaldehyde, thymol, squalene, rosmarinic acid, tyrosol, eugenol and -Caryophyllene 25 against Gram-positive and Gram-negative bacteria is here reported. Planktonic bacteria as well 26 as a model of biofilm forming bacteria were challenged against those components being 27 carvacrol, cinnamaldehyde and thymol the components with the highest antimicrobial action 28 in both different settings. The potential synergy of some of those components against 29 pathogenic bacteria was also analyzed. The antimicrobial mechanism of the different 30 components was analyzed by means of flow cytometry and by electronic and confocal 31 microscopy. Finally, subcytotoxic doses against mammalian cell lines are here reported to 32 highlight the reduced cytotoxicity of those components against eukaryotic cells. Carvacrol, 33 cinnamaldehyde and thymol showed the highest antimicrobial action of all the natural origin 34 compounds tested and lower cytotoxicity against eukaryotic cells than conventional antiseptics 35 such as chlorhexidine. The high inhibition in biofilm forming activity of those components 36 highlight also their demonstrate benefits in reducing pathogenic microorganisms. 37 38 Importance 39
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The use and misuse of antibiotics has led to the emergence of antibiotic resistance to human 40 and animal pathogens. Compounds from natural sources such as animals, plants, and 41 microorganisms have been proposed as renewed potential antimicrobial alternatives. The 42 comparative antimicrobial action of different components commonly present in essential oils 43 including carvacrol, cinnamaldehyde, thymol, squalene, rosmarinic acid, tyrosol, eugenol and 44 -Caryophyllene against S. aureus and E. coli is here reported. Carvacrol, cinnamaldehyde and 45 thymol are the components with the highest antimicrobial action. Bacteria membrane 46 disruption represents the bactericidal mechanism attributable to these compounds. In 3 1. Introduction 70 Since the discovery of penicillin the use of antibiotics, originally developed for human health 71 care, has been extended to animal therapeutics and agriculture (1). The use and misuse of 72 antibiotics has led to the emergence of antibiotic resistance to human and animal pathogens, 73 which is recognized as a serious and global concern because resistance to common bacteria 74 has reached alarming levels in all parts of the world (2). The continued evolution of 75 antimicrobial resistance (AMR) in the hospital is a growing concern because of its potential to 76 endanger the future of antimicrobial drug (3). Even the new generation of antibiotics is 77 becoming virtually ineffective and it is predicted that AMR will cause more deceases than 78 cancer-associated diseases by the middle of the century(4). The discovery of strains resistant 79 to all the antibiotics nowadays available in the clinic have also made an impact on society in 80 general (5). Resistance arises as a consequence of mutations in microbes. Sub-inhibitory 81 antibiotic doses help stepwise selection of resistance and the resulting resistant clones like 82 methicillin-resistant Staphylococcus aureus, Escherichia coli, and Klebsiella are rapidly 83 disseminated (6). The overall burden of staphylococcal disease caused by methicillin-resistant 84 S. aureus (MRSA) strains, is increasing in many countries in both health care and community 85 settings (7). Escherichia coli, a common gut bacterium in most mammal species is commonly 86 used to assess the impact of antimicrobials as it carries antibiotic resistance genes. Multiple 87 antimicrobial resistance determinants have been found in E. coli on the same plasmid, further 88 facilitating their propagation and co-selection. For instance, the multidrug resistance plasmid 89 IncA/C found in E. coli, often encodes for resistance to common antimicrobial agents such as 90 tetracycline, chloramphenicol/florfenicol, streptomycin/spectinomycin, sulfonamides, and 91 extended spectrum β-lactamases, and its spread to pathogenic bacteria may limit antibacterial 92 means to fight infections caused by these bacteria (3). 93 5 Because of the emergence of AMR the Center for Disease Control (CDC) has endorsed the need 94 for development of new antibiotics. However, the elaboration of new antibiotics is expensive 95 and time consuming. Meanwhile the genetic plasticity in pathogens results in the development 96 of resistance at a rapid rate (6). Therefore, there is a crucial need for research of new 97 substances with potential to combat resistant strains to minimize their selection. In 2011, 98 academics and industry collaborated on a priority list for approaches to resolve the 99 "antimicrobial-resistance crisis". Amongst the potential strategies proposed the development 100 of alternatives to antibiotics and the discovery or development of adjuvants were proposed 101 (8). Compounds from natural sources such as animals, plants, and microorganisms have been 102 proposed as renewed potential antimicrobial alternatives (9). Many of them are not new; they 103 have been used to prevent food spoilage since antiquity. Famous seafarers (e.g., Marco Polo) 104 established routes for specie trade and different compounds of natural origin present in 105 species are still being used nowadays to prevent foodborne pathogens showing low levels of 106 antimicrobial (10). Antibiotics by definition have a natural origin (i.e., penicillin is derived from 107
Penicillium fungi) and antimicrobials of synthetic origin used to fight against infection are 108 considered as drugs (i.e., isoniazid). However, there are several antibiotics that have multiple 109 mechanisms of action. In this regard, essential oils (EO) are oily aromatic substances extracted 110 from plants with antibacterial, antifungal, insecticidal and antiviral properties. Even when EOs 111 have been distilled for more than 2000 years there is now renewed interest in the 112 antimicrobial properties of phytochemicals and EOs in particular. It is very interesting the 113 demonstrated low levels of induction of antimicrobial resistance towards EOs, that could be 114 related to the fact that these substances do not attack a single specific target but have 115 multiple modes of antibacterial action (1). Antibiotic/drug combinations (i.e., in the treatment 116 of tuberculosis) follow the same principle to reduce the probabilities to develop mutations and 117 consequent drug or antibiotic resistance. Not only antibiotics, but also antiseptics like 118 chlorhexidine, have shown to be able to generate resistance in S. aureus and E. coli among other bacteria and concluded that cinnamaldehyde and carvacrol 150 not only exhibit high antibacterial activities but also have synergistic antimicrobial action 151 against these bacteria. Thymol and carvacrol were found to give an additive effect when tested 152 against S. aureus and P. aeruginosa (25), besides, thymol combined with carvacrol had a 153 synergistic effect against S. Typhimurium (26). One or more synergisms can produce the 154 desired antibacterial effect and reduce the amount of EO components necessary to obtain an 155 efficient bactericidal product. 156
One interesting application of EO components with antimicrobial activity would be their 157 incorporation into wound dressings since they can prevent or treat wound-associated 158 infections and aid during tissue regeneration (27). Bacterial components have been highlighted 159 as harmful factors during wound healing due to their interference with cell-matrix interactions 160 and due to a reduced inflammatory response they produce. In this regard, S. aureus colonize 161 from 30 to 50% of healthy adults and it is able to rapidly infect skin lesions with a 162 consequential inflammatory process (28). E. coli is also among the main bacterial species that 163 commonly colonize skin wounds and from this initial colonization, severe problems can occur 164 such as topical infections or even sepsis (29). Within the clinical settings, biofilm formation is a 165 pressing challenge that leads to chronic infections. Prevention of biofilm formation is 166 considered preferable to its removal, since the latter is a very difficult and demanding task, 167 which can cause recontamination problems due to the uncontrolled release of bacterial cells 168 and toxins after their disruption. One of the outstanding antimicrobial properties of many EOs 169 is that they can also be effective even against microbial biofilms (30). 
MIC and MBC values 179
The antibacterial effect of several components present in different essential oils reported as 180 bactericidal, such as carvacrol (31), thymol (32), cinnamaldehyde (33), eugenol (EU) (34), -181 caryophyllene (35) and rosmarinic acid (36) were studied. Squalene, a well-known natural 182 antioxidant (37) was also included in the study for comparison. Table 1 and Figure S1 
Bactericidal mechanism
187 E. coli and S. aureus exposed during 24 h to THY, CIN and CRV at MIC and MBC concentrations 188 were morphologically examined by SEM ( Figure 1) . The morphology and microstructure of S. 189 aureus before being exposed to any compound can be observed in Figure 1A Figure S4 ) indicate that only the CRV-THY combination has an additive effect, while 252 CIN has no interaction with the other compounds tested. The synergistic mechanism between 253 CIN with CRV or with THY was proposed to be caused by the increase in the membrane 254 permeability that enables CIN to be transported into the cell (45). But according to the treated 255 bacteria SEM micrographs (Figures 1 and 2) , flow cytometry histograms ( Figure S2 ) and 256 confocal microscopy images (Figures 3 and S3 ), the effect of the three compounds against E. 257 coli is mainly outer membrane disintegration and the morphology of treated S. aureus was 258 similar for the three active compounds. THY and CRV were previously found to give an additive 259 antimicrobial effect on S. aureus (25) as it was expected since both compounds have almost 260 the same molecular structure (Table 1) . It is worth noting that all the FICI values are smaller 261 than 4.0 indicating that there is no antagonism between the tested active compounds. 262 Figure 4A and B, respectively). The quantification (CFU/mL) carried 274 out after incubation of the formed biofilm ( Figure 5A ) with the antimicrobial compounds has 275 shown a statistically significant decrease in bacteria growth compared to the untreated 276 biofilms. At 0.5 mg/mL of EO-contained compounds, preformed biofilms showed a reduction in 277 bacteria growth around 2 logs when biofilm was treated with CIN, while CRV and THY exerted 278 a superior decrease (3 logs). The highest tested concentration (1 mg/mL) showed a reduction 279 in CFU/mL higher than 5 logs. As expected, concentrations of the active compounds higher 280 than MIC and even MBC values obtained for planktonic bacteria are needed for biofilm 281 elimination. Our study shows that concentrations higher than 1 mg/mL of any of the 282 compounds tested would be necessary for the total elimination of preformed biofilms. 283
Antibiofilm activity
The addition of EO-contained compounds to the bacteria suspension before biofilm formation 284 hindered this process since there was a significant decrease in the posterior bacterial growth 285 (4 logs for CIN) ( Figure 5B ). THY and CRV produced even higher reductions of about 5 and 6 286 logs, respectively. As expected, the concentrations needed to retard biofilm growth and 287 development were higher than the MIC values retrieved for planktonic bacteria (Table 1) but 288 they are in the same range than those reported in the literature (32). 289
Cytotoxicity

290
Non-cytotoxicity is required for a wound-healing product since it would be in contact with the 291 infected wound tissue and its neighbouring eukaryotic cells. The cytotoxicity activities of these 292 antimicrobial compounds were investigated using fibroblasts, macrophages and keratinocytes 293 cell lines ( Figure 6 ). Inflammatory cells such as macrophages are generated during wound 294 healing (49), on the other hand, keratinocytes and fibroblasts are part of the epidermis and 295 dermis, respectively. Due to the insolubility of those compounds in aqueous media, those were 296 dispersed thanks to the use of Tween® 80 as described in the materials and methods section. 297 13 Hence, the cytotoxicity of the free compounds would be reduced in absence of Tween® 80 due 298 to their nonpolar character. 299 CIN was the most cytotoxic chemical of the tested compounds; a dose of 0.030 mg/mL of this 300 compound was enough to reduce the viability of keratinocytes and macrophages below 70% 301 (lowest value established by the ISO 10993-5 to consider a material as non-cytotoxic) and 302 0.015 mg/mL affects the fibroblasts viability ( Figure 6 ). Thymol and carvacrol can be 303 considered toxic to fibroblasts at concentrations equal or higher than 0.090 mg/mL and the 304 calculated subcytotoxic doses for keratinocytes were 0.060 and 0.030 mg/mL, respectively. 305
There is also a difference between the effect of THY and CRV on macrophages, since 306 subcytotoxic concentrations were 0.060 and 0.090 mg/mL, respectively. Previous studies have 307 also studied the toxicity of different compounds present in EOs on different human cell lines, 308 such as fibroblasts (50), intestinal cells (51) or different tumor cells (52; 53). Their results show 309 subcytotoxic concentrations for carvacrol and thymol in the same range as ours (~500 µM) (51) 310 or higher (50% viability at ~5 µg/mL) (50) and also very similar for cinnamaldehyde (~10 311 µg/mL) (53) pointing to apoptosis and membrane damage as key cytotoxic mechanisms. 312
Chlorhexidine, a typical disinfectant and antiseptic drug used in skin disinfection, was tested 313 for comparison. For the studied concentrations (0.004-0.125mg/mL) chlorhexidine reduces the 314 viability of the three cellular types to 70% or below. Only fibroblasts show viability higher than 315 70% in presence of chlorohexidine at 0.004 mg/mL. For keratinocytes and macrophages the 316 subcytotoxic concentration was lower than 0.004 mg/mL. 317
These subcytotoxic values of the tested compounds were lower than the MICs and MBCs 318 retrieved for bacteria, but higher than those obtained with chlorhexidine. In order to reduce 319 bacterial burden in wounds, topical antiseptic agents, among them chlorohexidine gluconate, 320 are usually applied as 2 and 4 v/v % topical solutions (54), concentrations five orders of 321 magnitude higher than the subcytotoxic doses. Therefore, in our study the presence of 322 14 antibacterial compounds of natural origin in a wound dressing material at MBC concentrations 323 would be only three orders of magnitude higher than the subcytotoxic dose in the worst case 324 scenario demonstrating that those natural origin compounds are less harmful against 325 eukaryotic cells than conventional antiseptics. 326
Even though the studied compounds showed cytotoxic activity at doses above 0.090 and 0.060 327 mg/mL, it is important to point out that during the regenerative process in an infected wound 328 the antimicrobial compound at those doses would eradicate both bacteria and eukaryotic cells 329 but while bacteria are removed from the injury eukaryotic cells are continuously arriving to the 330 wound to participate in the regenerative process. Hence, only a small fraction of eukaryotic 331 cells would be eliminated. 332 bacteria membrane disruption is the bactericidal mechanism attributable to CRV, CIN and THY. 339 There is no antagonism between the tested active compounds, but no synergism was found 340 either; only the CRV-THY combination showed an additive effect. The presence of those 341 compounds at concentrations above 0.5 mg/mL not only hinders S. aureus biofilm formation 342 but also partially eliminates preformed biofilms. The subcytotoxic values of the tested EO 343 compounds (in the range 0.015-0.090 mg/mL) are lower than MICs and MBCs for bacteria, but 344 much higher than chlorhexidine doses (0.004 mg/mL). The presence of those antibacterial 345 compounds at MBC concentrations would be only three orders of magnitude higher than the 346 subcytotoxic dose in the worst-case scenario. were obtained from Gibco (UK) and the Blue Cell Viability assay from Abnova (Taiwan). 360
Conclusions
Bacteria culture 361
As Gram-negative model E. coli S17 strain was used, which was kindly donated by Dr. Jose 362 Antonio Ainsa, while S. aureus was evaluated as a Gram-positive model. Both strains were 363 initially grown overnight in TSB at 37 ºC under shaking (150 rpm) obtaining, in stationary 364 growth phase, 10 8 -10 9 colony forming units/mL (CFU/mL). TSA was used for seeding bacteria in 365 an incubator at 37 ºC (Memmert, Germany) in order to calculate the bacteria growth (CFU/mL) 366 after treatment with the EO-contained compounds. 367 bacteria were adjusted to 10 7 CFU/mL and added to a MW96 microplate and incubated at 37 370 ºC for 16 h without shaking. After incubation, culture medium was discarded and biofilms were 371 washed twice with PBS. In order to determine biofilm formation, Calcofluor White Stain was 372 16 added to each well and incubated 1 min in the dark at room temperature. After incubation, 373 the stain was removed and biofilms were washed twice with PBS. Samples were air-dried in 374 the dark to be further visualized in an inverted fluorescence microscope (Olympus IX81). 375
Biofilm formation
To be analyzed by SEM biofilms were grown on sterile glass slides incubated in a S. aureus 376 planktonic suspension (10 7 CFU/mL) at 37 ºC for 16 h without shaking. Then, biofilms were 377 washed twice with PBS (0.1 M) and fixed in 2.5% glutaraldehyde for 3 h. Samples were 378 dehydrated through a series of ethanol solutions (30, 50, 70, 80, 90 and 100%; 15 min, twice). 379
Finally, samples were air-dried at room temperature and coated with Pt to allow electronic 380 observation. SEM images were acquired in the energy range of 10-15 keV in a SEM Inspect™ 381 F50 (FEI Co., LMA-INA, Spain). 382 
Antibacterial activity
MIC and MBC determination 384
Inhibitory and bactericidal concentrations of active EO compounds were tested in two bacteria 385 cultures, E. coli and S. aureus, following the broth microdilution method. Liquid growth 386 medium containing an inoculum of 10 5 CFU/mL and serial concentrations of the EO 387 compounds (0.1-4 mg/mL) were used. EO compounds were solubilized in culture medium by 388 adding Tween® 80 (1.5-2% v/v) prior to their serial dilution. Once bacteria suspension was in 389 stationary growth (10 8 -10 9 CFU/mL) it was further diluted to ~10 5 CFU/mL and added to 390 different concentrations of the antimicrobial agents. Then, samples were incubated for 24 h at 391 37 ºC under shaking (150 rpm). After incubation, bacterial suspensions were diluted in PBS and 392 spot-plated on TSA plates to count colonies after incubation at 37 ºC for 24 h. Positive control 393 (untreated bacteria) and negative control (chlorhexidine treated bacteria) samples were also 394 tested. 395
SEM 396
Bacteria morphology before and after treatment with EO compounds was analyzed by SEM as 397 we previously reported (55). Briefly, logarithmic growth phase E. coli and S. aureus bacteria 398 cultures (~10 5 CFU/mL) were treated with the selected EO compounds at MIC and MBC values 399 and incubated overnight at 37 ºC. Following incubation, samples were spin-dried at 600g and 400 washed twice in PBS (0.1 M). Bacteria were fixed in 2.5% glutaraldehyde for 90 min and 401 subsequently filtered and dehydrated in ethanol solutions series (30, 50, 70, 80, 90 and 100%; 402 twice for 15 min). Finally, samples were air-dried at room temperature and covered with Pt. 403 SEM micrographs were acquired in a SEM Inspect F50 equipment (FEI Co., LMA-INA, Spain). 404
Flow cytometry 405
In order to study the bactericidal mechanism of the different compounds present in EOs E. coli 406 and S. aureus bacteria samples (10 7 CFU/mL) were centrifuged at 4400g for 10 min and 407 resuspended in the different compound solutions at MIC and MBC concentrations following 408 the protocols previously described (40; 55). Control groups (not treated and chlorhexidine 409 treated bacteria) were also analyzed. All samples were incubated overnight at 37°C. After 410 propidium iodide (25 µg/mL; Sigma-Aldrich, Germany) addition samples were analyzed by flow 411 cytometry in a Gallios equipment (Beckman Coulter Company, Cell Separation and Cytometry 412 Unit, CIBA, IIS Aragon, Spain). 413
Confocal microscopy 414
Live/Dead®BacLight™ bacterial viability kit (Molecular Probes, Fisher Scientific, Spain) was 415 used to detect bacteria membrane damage. The methodology is based on the double-staining 416 by SYTO9 and propidium iodide as indicated by the manufacturer. Bacteria samples (10 7 417 CFU/mL) treated with the selected EO compounds at MIC were put in contact with the dye 418 mixture for 15 min in the dark at room temperature. Samples were then mounted on slides 419 and visualized by confocal microscopy (Leica TCS SP2 Laser Scanning Confocal Microscope, 420 18 Microscopy Unit, CIBA, IIS Aragon, Spain). Control samples were also tested as described 421 above. 422
Synergy studies 423
The Broth Dilution Checkerboard test was used to evaluate the interaction among the three 424 most promising bactericidal EO compounds determined by the MIC and MBC studies against S. 425 aureus as previously reported (56). In brief, a solution containing 4 times the MBC of each 426 compound was prepared. By using a MW96 plate and fresh medium, compound A was diluted 427 two-fold in vertical orientation and compound B was diluted two-fold in horizontal direction. 428
Then, a bacterial suspension (10 6 CFU/mL, 100 µL) was added and the plate was incubated 429 overnight at 37 °C. After incubation, bacteria growth was determined by the resazurin assay. FICI results were classified as synergy (FICI < 0.5), addition (0.5 ≤ FICI ≤ 1), indifference (1 < FIC 436 I≤ 4) or antagonism (FICI > 4), as previously described (57). 437
Biofilm disruption 438
The effects of EO compounds (0.25-1 mg/mL) to prevent the formation of biofilm and to 439 disrupt an already formed S. aureus biofilm were studied. EO compounds were added to 440 preformed biofilms and samples were incubated for 24 h at 37 ºC without shaking. After 441 incubation, biofilms were disrupted by sonication (15 min, 200 W; Ultrasons, JP Selecta, Spain). 442
Samples were then diluted and seeded onto agar plates to count the viable colonies grown 443 after 24 h of incubation at 37 ºC. 444
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To study the effects of the compounds present in the EOs on biofilm formation, those were 445 added to bacterial suspensions (10 7 CFU/mL) in a MW96 microplate and incubated for 16 h at 446 37 ºC without shaking. After incubation, planktonic cells were removed by washing them twice 447 with PBS. Biofilm samples were then sonicated as described above and serially diluted to be 448 further plated on agar. Viable bacteria (CFU/ mL) were counted after 24 h of incubation at 37 449 ºC. 450 The cytotoxicity was determined by measuring cell metabolism through the Blue Cell Viability 461 assay. Cells were seeded on MW96 microplates and incubated with the tested compounds 462 (0.004-0.125 mg/mL) for 24 h. Control samples (not treated and chlorhexidine treated) were 463 also analyzed. Then, the reagent was added (10%) and cells were incubated for 4 h at 37 ºC. 464
Cell culture and cytotoxicity assays
The reduction of the dye by metabolically active cells was monitored in a microplate reader 465 
